Mika Kurkela

5PUBLICATIONS
20CO-AUTHORS
Biologically active moleculesPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Clinical chemistry (incl. diagnostics)Cheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 14, 2025
Repeated Intake of Grapefruit Juice Inhibits CYP2B6, CYP2C9, CYP2C19, and CYP3A4 while Lingonberry Powder Does Not Induce Major CYP Enzymes in Humans.

Laura Aurinsalo, Outi Lapatto-Reiniluoto, Mika Kurkela

|Feb 21, 2025
A Phenotyping Tool for Seven Cytochrome P450 Enzymes and Two Transporters: Application to Examine the Effects of Clopidogrel and Gemfibrozil.

Laura Aurinsalo, Outi Lapatto-Reiniluoto, Mika Kurkela

|Oct 03, 2023
Ticagrelor Increases Exposure to the Breast Cancer Resistance Protein Substrate Rosuvastatin.

Minna Lehtisalo, E Katriina Tarkiainen, Mikko Neuvonen

|May 23, 2023
Introduction of an electrochemical point-of-care assay for quantitative determination of paracetamol in finger-prick capillary whole blood samples.

Johanna Kujala, Niklas Wester, Terhi J Lohela

|Nov 29, 2022
Hydroxychloroquine is Metabolized by Cytochrome P450 2D6, 3A4, and 2C8, and Inhibits Cytochrome P450 2D6, while its Metabolites also Inhibit Cytochrome P450 3A in vitro.

Marie-Noëlle Paludetto, Mika Kurkela, Helinä Kahma

Pageof 1